Hyperactivated FRS2α-mediated signaling in prostate cancer cells promotes tumor angiogenesis and predicts poor clinical outcome of patients.
about
DHX32 Promotes Angiogenesis in Colorectal Cancer Through Augmenting β-catenin Signaling to Induce Expression of VEGFAOverexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer.Fibroblast growth factors, old kids on the new block.Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors.Fibroblast growth factor-mediated crosstalk in cancer etiology and treatment.FGF19 genetic amplification as a potential therapeutic target in lung squamous cell carcinomas.
P2860
Hyperactivated FRS2α-mediated signaling in prostate cancer cells promotes tumor angiogenesis and predicts poor clinical outcome of patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Hyperactivated FRS2α-mediated ...... clinical outcome of patients.
@ast
Hyperactivated FRS2α-mediated ...... clinical outcome of patients.
@en
type
label
Hyperactivated FRS2α-mediated ...... clinical outcome of patients.
@ast
Hyperactivated FRS2α-mediated ...... clinical outcome of patients.
@en
prefLabel
Hyperactivated FRS2α-mediated ...... clinical outcome of patients.
@ast
Hyperactivated FRS2α-mediated ...... clinical outcome of patients.
@en
P2093
P2860
P356
P1433
P1476
Hyperactivated FRS2α-mediated ...... clinical outcome of patients.
@en
P2093
W L McKeehan
P2860
P2888
P304
P356
10.1038/ONC.2015.239
P407
P577
2015-06-22T00:00:00Z
P6179
1004734003